Allianz Asset Management Gmb H Zai Lab LTD Transaction History
Allianz Asset Management Gmb H
- $74.9 Billion
- Q2 2025
A detailed history of Allianz Asset Management Gmb H transactions in Zai Lab LTD stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 932,000 shares of ZLAB stock, worth $30.4 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
932,000
Previous 1,884,411
50.54%
Holding current value
$30.4 Million
Previous $68.1 Million
52.14%
% of portfolio
0.04%
Previous 0.1%
Shares
24 transactions
Others Institutions Holding ZLAB
# of Institutions
170Shares Held
38.6MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$197 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$180 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$131 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$71.6 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$51.7 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $3.19B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...